Clinical evaluation of beta-adrenergic inhibitors based on records examined by the Committee for Marketing Authorization
Baumelou, A.; Baron, M.P.
Therapie 40(6): 431-432
1985
ISSN/ISBN: 0040-5957 PMID: 2868541 Document Number: 260398
Document emailed within 1 workday
Related Documents
Müllner, M.; Vamvakas, S.; Rietschel, M.; van Zwieten-Boot, B.J. 2007: Are women appropriately represented and assessed in clinical trials submitted for marketing authorization? A review of the database of the European Medicines Agency International Journal of Clinical Pharmacology and Therapeutics 45(9): 477-484Bruynzeel, P.L. 1984: Changes in the beta-adrenergic system due to beta-adrenergic therapy: clinical consequences European Journal of Respiratory Diseases. Supplement 135: 62-71
Seitz, R. 2006: EU procedures for marketing authorization of pharmaceutical products ArbeitenausdemPaul-Ehrlich-InstitutZuFrankfurtA.M2006(95): 60
Di Mattéo, J.; Vacheron, A.; Heulin, A.; Delvaux, J.C. 1971: Use of adrenergic beta inhibitors in angina pectoris Annales de Medecine Interne 122(2): 243-248
Malcolm, J.; Malcolm-Thomas, B.; Comhaire, E. 1970: Current status of knowledge concerning adrenergic beta receptor inhibitors Acta Cardiologica 25(3): 260-279
Mouillé, P. 1970: Interactions between various alpha and beta adrenergic inhibitors and ergotamine during inversion of the pressure effects of isoprenaline in the dog Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(5): 1003-1006
Mickey, J.V.; Tate, R.; Mullikin, D.; Lefkowitz, R.J. 1976: Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro Molecular Pharmacology 12(3): 409-419
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Szymański, P.T. 1983: Beta adrenergic receptors in the rat myocardium. II. Determination of the kinetic parameters of interaction of J-125-labeled hydroxybenzylpindolol with beta adrenergic receptors Endokrynologia Polska 34(5): 305-314
Kopeć, J. 1986: Quantitative evaluation of EMG records based on 2 digital indicators Neurologia i Neurochirurgia Polska 20(1): 18-23
Miyazaki, M.; Nioka, S.; Fujita, T. 1975: Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin) Masui. Japanese Journal of Anesthesiology 24(1): 56-63
Downing, J.W. 1978: Clinical usefulness of the beta-adrenergic antagonists South African Medical Journal 54(17): 687
Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C. 1985: Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids Medicina Clinica 85(2): 53-57
Yamaguchi, Y. 2006: Structure-based drug design of the irreversible inhibitors of metallo-beta-lactamases Japanese Journal of Antibiotics 59(1): 51-56
Xie, Y.; Wang, Y.; Tian, F.; Wang, Y. 2011: Basic requirements on post-marketing clinical re-evaluation of chinese medicine and phase IV clinical trials Zhongguo Zhong Yao Za Zhi 36(20): 2764-2767
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
King, G.J.; Randall, L.F. 1974: Official lactation records received in 1973, by State; Summary of Official lactation records reported since 1957; Records reported but not used in genetic evaluation 1973; Sire identification in Official lactation records, 1969-1973, by State; Summary of the use of Offical records for bull and cow evaluation; Percentage of cows with sire identification Dairy Herd Improvement Letter 50(2): 8
Monteiro Trinidade, A.; Costa Trindade, J.; Palma Carlos, A.C.; De Pádua, F. 1973: Beta-adrenergic block and ventilatory function. Clinical aspects Minerva Medica 64(41): 2190-2199
Bauer, G.E.; Michell, G. 1970: Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug Medical Journal of Australia 1(4): 170-173
Obukhov, G.A. 1981: Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 81(5): 746-761